Oncology PracticeRituximab improves salvage in elderly B-cell lymphoma patientsOctober 23, 2017Lymphoma & Plasma Cell DisordersAggressive LymphomasB Cell Lymphoma
Hematology NewsIrradiation safe, effective as chemotherapy before cell transplant in mantle cell lymphomaOctober 23, 2017Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology TimesNew assay may aid diagnosis, treatment of DLBCLOctober 23, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesWhat we don’t know about BIA-ALCLOctober 20, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCAR T-cell therapy approved to treat lymphomasOctober 19, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesGel shows promise for treating early stage MFOctober 17, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesCryotherapy can reduce signs of CIPNOctober 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaRelated Issues
Hematology TimesNatural selection opportunities tied to cancer ratesOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaCML
Hematology TimesNCCN completes resource on radiation therapyOctober 13, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesPredicting neurotoxicity after CAR T-cell therapyOctober 12, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesImmunotherapy demonstrates potential for T-cell lymphomaOctober 11, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesFDA rejects pegfilgrastim biosimilarOctober 11, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Hematology TimesTeam identifies genetic drivers of DLBCLOctober 10, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesPrimary care may be inadequate for cancer survivorsOctober 9, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaPediatricsRelated Issues
Hematology NewsObinutuzumab edges out rituximab for PFS in follicular lymphomaOctober 6, 2017Aggressive LymphomasLymphoma & Plasma Cell DisordersFollicular Lymphoma
